SOURCE: StockCall


June 27, 2012 08:20 ET

Equity Research on Unitedhealth Group Inc. and Humana Inc. - Health Care Plan Providers Waiting on Supreme Court Ruling

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 27, 2012) - offers free research on Unitedhealth Group Inc. (NYSE: UNH) and Humana Inc. (NYSE: HUM) from the Health Care Plans industry. Access these reports by clicking on the links below or by copy and pasting those to your address bar.

All eyes in the health care industry are on the Supreme Court this week as it gets set to make a ruling on the Affordable Health Care Act. Plan providers like Unitedhealth Group Inc. and Humana Inc. are companies that will be affected regardless of the decision. is an online platform where investors doing their due-diligence on the Health Care Plans industry can have easy and free access to our analyst research and opinions on Unitedhealth Group Inc. and Humana Inc. To see how companies in this industry have grown over the past years and how they are expected to perform in the future, please visit the link below.

The outcome can be broken down in essentially three ways:

If the ruling is upheld and the individual mandate requiring all citizens to be insured is overruled, insurers could lose out when healthy individuals avoid coverage and they are left covering those with prior (and costly) medical conditions. Investors and shareholders of Unitedhealth Group Inc. can simply register for our complimentary reports by clicking on the link below.

If both the new coverage rules and individual mandate are repealed, insurers would likely profit because they would be able to reject individuals that sign up once they become sick. Register now to have free access to our report on Humana Inc., and to do so please click the link below.

If the whole law is repealed, insurers could potentially lose out on a substantial pool of patients added to their coverage. Additionally, all of the efforts made to adjust to the new law could be made moot and insurers would again be forced to acclimate to yet another regulatory landscape.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information